for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

MicroPort Scientific Corporation

0853.HK

Latest Trade

7.96HKD

Change

-0.20(-2.45%)

Volume

2,881,149

Today's Range

7.90

 - 

8.24

52 Week Range

5.21

 - 

11.24

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
8.16
Open
8.16
Volume
2,881,149
3M AVG Volume
107.29
Today's High
8.24
Today's Low
7.90
52 Week High
11.24
52 Week Low
5.21
Shares Out (MIL)
1,618.25
Market Cap (MIL)
13,204.96
Forward P/E
35.08
Dividend (Yield %)
0.36

Next Event

Full Year 2019 Microport Scientific Corp Earnings Release

Latest Developments

More

Microport Scientific Posts HY Profit Attributable $65.5 Mln Vs $23.8 Mln

Microport Scientific Corp Updates On Registration For Proposed Offering Shares Of EV Medtech

Microport Scientific Sees One-Off Gain On Disposal Of Interests In Microport EP Medtech

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About MicroPort Scientific Corporation

MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.

Industry

Medical Equipment & Supplies

Contact Info

No. 1601 Zhangdong Road

Zhangjiang Hi-Tech Park

+86.21.38954600

http://www.microport.com.cn

Executive Leadership

Zhaohua Chang

Executive Chairman of the Board, Chief Executive Officer

Hongbin Sun

Chief Financial Officer

Junder Chiang

Chief Human Resource Officer

Jonathan W. Chen

Senior Vice President - International Operations & Investor Relations

Qiyi Luo

Chief Technology Officer

Key Stats

2.33 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.4K

2017

0.4K

2018

0.7K

2019(E)

0.8K
EPS (USD)

2016

0.010

2017

0.013

2018

0.013

2019(E)

0.030
Price To Earnings (TTM)
28.40
Price To Sales (TTM)
2.24
Price To Book (MRQ)
3.35
Price To Cash Flow (TTM)
16.32
Total Debt To Equity (MRQ)
75.67
LT Debt To Equity (MRQ)
37.69
Return on Investment (TTM)
7.02
Return on Equity (TTM)
4.32

Latest News

BRIEF-Microport Scientific Updates On Acquisition Of Business From Livanova PLC

* SELLER HAS AGREED TO SELL, CRM BUSINESS FOR AN INITIAL CONSIDERATION OF US$190 MILLION Source text for Eikon: Further company coverage:

BRIEF-Livanova Enters Agreement To Divest Cardiac Rhythm Management Business To Microport Scientific Corp

* LIVANOVA ENTERS INTO DEFINITIVE AGREEMENT TO DIVEST ITS CARDIAC RHYTHM MANAGEMENT BUSINESS FRANCHISE TO MICROPORT SCIENTIFIC CORPORATION

BRIEF-Microport Scientific Corp Sees 30% To 35% Increase In Profit Attributable For FY2017

* SEES 30% TO 35% INCREASE IN PROFIT ATTRIBUTABLE TO EQUITY SHAREHOLDERS OF COMPANY FOR YEAR ENDED 31 DECEMBER 2017

BRIEF-LivaNova says breaching co to pay $6 mln if deal with Microport collapses

* LivaNova - If deal to sell co's cardiac rhythm management business to Microport Cardiac Rhythm terminated, breaching party to pay termination fee of $6 million Source text: (http://bit.ly/2z3iI02) Further company coverage:

BRIEF-Microport Scientific's unit buys CRM business from Livanova

* Unit buys CRM business for initial consideration of US$190 million from Livanova PLC Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

BRIEF-Microport Scientific posts HY profit attributable of $21.4 mln

* HY profit attributable to equity shareholders us$21.4 million, up 355.8% Source text for Eikon: Further company coverage:

BRIEF-Microport Scientific Corp announces proposed transfer of equity interest in Mp Cardioflow

* Announces proposed transfer of equity interest in mp cardioflow and proposed capital increase of mp cardioflow

BRIEF-Microport Scientific expects net profit of about $20 mln for HY ended 30 June 2017

* Group is expected to record a net profit of approximately $20 million for six months ended 30 june 2017

BRIEF-Microport Scientific updates on transfer of interest in Microport Endovascular Shanghai

* Sale side companies and target company entered into equity transfer agreement with fufu

BRIEF-Microport Scientific Corp unit enters into equity transfer agreements

* Sale side companies and target company entered into equity transfer agreements with relevant investors

BRIEF-Microport Scientific enters distribution and service deals

* Company and Otsuka entered into distribution framework agreement

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up